These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 8125714

  • 1. Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis.
    Callegan MC, Engel LS, Hill JM, O'Callaghan RJ.
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1033-7. PubMed ID: 8125714
    [Abstract] [Full Text] [Related]

  • 2. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
    Dajcs JJ, Hume EB, Moreau JM, Caballero AR, Cannon BM, O'Callaghan RJ.
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.
    Callegan MC, Hobden JA, Hill JM, Insler MS, O'Callaghan RJ.
    Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3017-23. PubMed ID: 1399405
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Lauffenburger MD, Cohen KL.
    Cornea; 1993 Nov; 12(6):517-21. PubMed ID: 8261784
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
    Moreau JM, Green LC, Engel LS, Hill JM, O'Callaghan RJ.
    Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996
    [Abstract] [Full Text] [Related]

  • 8. Rabbit Streptococcus pneumoniae keratitis model and topical therapy.
    Guzek JP, Cline DJ, Row PK, Wessels IF, Beeve S, Ispirescu S, Aprecio RM, Kettering JD, Gano DL, Nelson GM.
    Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2012-7. PubMed ID: 9761279
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis.
    Reidy JJ, Hobden JA, Hill JM, Forman K, O'Callaghan RJ.
    Cornea; 1991 Jan; 10(1):25-8. PubMed ID: 1902152
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis.
    Hobden JA, Reidy JJ, O'Callaghan RJ, Insler MS, Hill JM.
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2241-3. PubMed ID: 2173684
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of tobramycin drops applied to collagen shields for experimental staphylococcal keratitis.
    Callegan MC, Engel LS, Clinch TE, Hill JM, Kaufman HE, O'Callaghan RJ.
    Curr Eye Res; 1994 Dec; 13(12):875-8. PubMed ID: 7720394
    [Abstract] [Full Text] [Related]

  • 14. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
    Balzli CL, McCormick CC, Caballero AR, Huang B, Wigington L, Smith E, Tang A, O'Callaghan RJ.
    J Cataract Refract Surg; 2008 Feb; 34(2):295-301. PubMed ID: 18242457
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
    Dajcs JJ, Thibodeaux BA, Marquart ME, Girgis DO, Traidej M, O'Callaghan RJ.
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1948-52. PubMed ID: 15155183
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin.
    Callegan MC, Hill JM, Insler MS, Hobden JA, O'Callaghan RJ.
    Curr Eye Res; 1992 Nov; 11(11):1111-9. PubMed ID: 1483341
    [Abstract] [Full Text] [Related]

  • 20. Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
    Kowalski RP, Romanowski EG, Mah FS, Shanks RM, Gordon YJ.
    Acta Ophthalmol; 2010 Jun; 88(4):e120-5. PubMed ID: 20456251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.